Abstract
177P - The impact of the 21-gene assay in the Czech Republic on adjuvant chemotherapy (CT) recommendations and costs in estrogen receptor positive (ER+) early stage breast cancer (ESBC) patients with grade 2 tumors and risk factors
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have